Conserved and Divergent Roles of FGF Signaling in Mouse Epiblast Stem Cells and Human Embryonic Stem Cells

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Boris Greber - , Max Planck Institute for Molecular Biomedicine (Author)
  • Guangming Wu - , Max Planck Institute for Molecular Biomedicine (Author)
  • Christof Bernemann - , Max Planck Institute for Molecular Biomedicine (Author)
  • Jin Young Joo - , Max Planck Institute for Molecular Biomedicine (Author)
  • Dong Wook Han - , Max Planck Institute for Molecular Biomedicine (Author)
  • Kinarm Ko - , Max Planck Institute for Molecular Biomedicine (Author)
  • Natalia Tapia - , Max Planck Institute for Molecular Biomedicine (Author)
  • Davood Sabour - , Max Planck Institute for Molecular Biomedicine (Author)
  • Paul Tesar - , Case Western Reserve University (Author)
  • Hans R. Schöler - , Max Planck Institute for Molecular Biomedicine, University of Münster (Author)
  • Jared Lynn Sterneckert - , Max Planck Institute for Molecular Biomedicine (Author)

Abstract

Mouse epiblast stem cells (EpiSCs) are cultured with FGF2 and Activin A, like human embryonic stem cells (hESCs), but the action of the associated pathways in EpiSCs has not been well characterized. Here, we show that activation of the Activin pathway promotes self-renewal of EpiSCs via direct activation of Nanog, whereas inhibition of this pathway induces neuroectodermal differentiation, like in hESCs. In contrast, the different roles of FGF signaling appear to be only partially conserved in the mouse. Our data suggest that FGF2 fails to cooperate with SMAD2/3 signaling in actively promoting EpiSC self-renewal through Nanog, in contrast to its role in hESCs. Rather, FGF appears to stabilize the epiblast state by dual inhibition of differentiation to neuroectoderm and of media-induced reversion to a mouse embryonic stem cell-like state. Our data extend the current model of cell fate decisions concerning EpiSCs by clarifying the distinct roles played by FGF signaling.

Details

Original languageEnglish
Pages (from-to)215-226
Number of pages12
JournalCell Stem Cell
Volume6
Issue number3
Publication statusPublished - 5 Mar 2010
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 20207225
ORCID /0000-0002-7688-3124/work/142250048

Keywords

Keywords

  • STEMCELL

Library keywords